Targeting viral infection by microRNA inhibition.

PubWeight™: 0.83‹?›

🔗 View Article (PMC 2847709)

Published in Genome Biol on January 26, 2010

Authors

Ashley P E Roberts1, Catherine L Jopling

Author Affiliations

1: School of Pharmacy, Centre for Biomolecular Sciences, University of Nottingham, University Park, Nottingham NG7 2RD, UK.

Articles cited by this

Silencing of microRNAs in vivo with 'antagomirs'. Nature (2005) 32.56

Origins and Mechanisms of miRNAs and siRNAs. Cell (2009) 20.77

Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science (2005) 16.84

MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods (2007) 13.94

miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab (2006) 12.41

LNA-mediated microRNA silencing in non-human primates. Nature (2008) 11.45

Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science (2009) 10.30

Cellular cofactors affecting hepatitis C virus infection and replication. Proc Natl Acad Sci U S A (2007) 6.79

miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol (2004) 6.44

Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res (2007) 5.67

Unravelling hepatitis C virus replication from genome to function. Nature (2005) 5.25

microRNA-122 stimulates translation of hepatitis C virus RNA. EMBO J (2008) 4.24

Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome. Cell Host Microbe (2008) 3.73

Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy. Nat Med (2009) 3.72

The role of RNAi and microRNAs in animal virus replication and antiviral immunity. Genes Dev (2009) 3.30

miR-122 targeting with LNA/2'-O-methyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA-peptide conjugates. RNA (2007) 1.90

Modulation of hepatitis C virus RNA abundance and the isoprenoid biosynthesis pathway by microRNA miR-122 involves distinct mechanisms. J Virol (2010) 1.88

Mechanisms of antiviral treatment efficacy and failure in chronic hepatitis C. Antiviral Res (2003) 1.47

Experimental models for hepatitis C viral infection. Hepatology (2009) 1.15

Hepatitis C drug development at a crossroads. Hepatology (2009) 0.92

Hepatitis C virus: the growing challenge. Br Med Bull (2009) 0.89